EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study

Jiaxin Xie, Xuesi Dong, Zilin Luo iD, Chenran Wang iD, Yadi Zheng, Xiaolu Chen iD, Zeming Guo, Xiaoyue Shi, Fei Wang, Wei Cao, Yongjie Xu, Le Wang iD und 4 weitere

PLOS Medicine · 2025

DOI: 10.1371/journal.pmed.1004807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Medicine, 2025. Verfasst von Jiaxin Xie und 15 weiteren Autor:innen. Beteiligte Einrichtung: Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Patient Compliance, Mass Screening. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Science, nonprofit Central Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adherence to colorectal cancer (CRC) screening remains suboptimal in many countries, reducing its cost-effectiveness. This study aimed to evaluate how multistage uptake rates influence the health benefit and cost-effectiveness of various CRC screening strategies in the Chinese population, incorporating both traditional and emerging screening methods. Methods and findings We developed a multistate Markov model (CRC-SIM) to evaluate the impact of multistep uptake on CRC screening. A hypothetical cohort of 100,000 individuals aged 40 was simulated and followed until 79 or death. Two-step screening strategies were modeled: initial screening followed by colonoscopy after a positive result. Traditional initial screening methods include: questionnaire-based risk assessment, fecal immunochemical test (FIT), and questionnaire combined with FIT; Non-invasive biomarker-based initial strategies include a hypothetical test meeting the minimum standards of China National Medical Products Administration ( NMPA min ), multitarget stool DNA (mt-sDNA) test, and blood-based strategies. All strategies were modeled as one-time screenings, with outcomes projected for CRC cases, deaths, quality-adjusted life years (QALYs), and lifetime costs. Incremental cost-effectiveness ratios (ICERs) were calculated, and a cost-effectiveness heatmap was conducted to assess the impact of multistep uptake (modeled in 10% steps) on economic outcomes. All strategies reduced CRC cases, deaths and increased QALYs compared to no screening, with biomarker-based strategies outperforming the traditional methods at the same uptake level (e.g., questionnaire combined with FIT prevented 224 (95% confidence interval (CI) [157, 292]) CRC cases and 151 (95% CI [109, 195]) deaths, whereas NMPA min prevented 312 (95% CI [257, 360]) cases and 210 (95% CI [175, 241]) deaths at 100% uptake). The cost-effectiveness heatmap indicated that each 10% increase in initial and follow-up colonoscopy uptake improved ICERs in a non-linear pattern. The questionnaire combined with FIT was the most cost-effective strategy (ICER = $2,413 per QALY gained). Non-invasive biomarker-based tests were not cost-effective compared with the combined questionnaire and FIT strategy under current assumptions of test costs and identical uptake rate. Threshold analysis showed that non-invasive biomarker-based screening would become cost-effective if test costs fell below $131.7 or colonoscopy uptake increased to at least 70% for NMPA min and 50% for blood-based tests and mt-sDNA. Limitations include the assumption of a one-time screening scenario; future iterations of the model and merging evidence in repeated screening will address these limitations.

Conclusion

Improving screening participation could enhance health benefits and cost-efficiency in CRC screening. Questionnaire-based risk assessment combined with FIT was a cost-effective strategy in China, whereas non-invasive biomarker-based methods require cost reduction and higher uptake to justify adoption. These findings provide evidence for policymakers to optimize CRC screening programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEarly Detection of CancerPatient ComplianceMass ScreeningHumansCost-Benefit AnalysisMiddle AgedMaleFemaleAgedChinaColonoscopyQuality-Adjusted Life YearsMarkov ChainsAdultOccult BloodSurveys and Questionnaires

Autor:innen und Institutionen

  • Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Department of Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing,…
  • Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical Un…

ORCID-Profile: Zilin Luo, Chenran Wang, Xiaolu Chen, Le Wang, Ni Li

Förderung

  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Science
  • nonprofit Central Research Institute
  • noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Xie, J., Dong, X., Luo, Z., Wang, C., Zheng, Y., Chen, X., Guo, Z., Shi, X., Wang, F., Cao, W., Xu, Y., Wang, L., Wu, W., Hang, D., Du, L., & Li, N. (2025). The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004807

Vancouver

Xie J, Dong X, Luo Z, Wang C, Zheng Y, Chen X, et al. The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study. PLOS Medicine. 2025. doi:10.1371/journal.pmed.1004807

BibTeX
@article{Xie2025,
  author = {Xie, Jiaxin and Dong, Xuesi and Luo, Zilin and Wang, Chenran and Zheng, Yadi and Chen, Xiaolu and Guo, Zeming and Shi, Xiaoyue and Wang, Fei and Cao, Wei and Xu, Yongjie and Wang, Le and Wu, Weimiao and Hang, Dong and Du, Lingbin and Li, Ni},
  title = {The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study},
  journal = {PLOS Medicine},
  year = {2025},
  doi = {10.1371/journal.pmed.1004807}
}
Kostenlos starten →